scholarly journals Hepatectomy of living donors with a left-sided gallbladder and multiple combined anomalies for adult-to-adult living donor liver transplantation

2004 ◽  
Vol 10 (1) ◽  
pp. 141-146 ◽  
Author(s):  
Shin Hwang ◽  
Sung-Gyu Lee ◽  
Kwang-Min Park ◽  
Young-Joo Lee ◽  
Chul-Soo Ahn ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation

scholarly journals Morbidity and Mortality of Hepatic Right Lobe Living Donors: Systematic Review and Perspectives

2018 ◽  
Vol 27 (2) ◽  
pp. 169-178 ◽  
Author(s):  
Pauline Brige ◽  
Géraldine Hery ◽  
Sophie Chopinet ◽  
Anaïs Palen ◽  
Daniel Azoulay ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Morbidity And Mortality ◽  
Donor Liver ◽  
Mortality And Morbidity ◽  
Donor Liver Transplantation ◽  
Portal Vein Flow ◽  
Mesh Terms

Background & Aims: The main restriction in the development of adult-adult Living Donor Liver Transplantation (LDLT) is the risk of morbidity and mortality for donors, which raises ethical questions. The objectives of this study are to review published studies dealing with morbidity and mortality in LDLT and to identify the proposed management and strategies for preventing donor mortality and morbidity in LDLT.Methods: The Medline database was searched from 2000 to 2017 using the MeSH terms “liver transplantation” and “morbidity” or “mortality” in combination with keywords “living donor liver transplantation”.Results: Among the 382 articles obtained, 43 articles were relevant for morbidity, 15 for mortality and 6 for both morbidity and mortality. Twenty-three papers reported donor deaths. The major cause of death was sepsis (30%). Morbidity ranged from 10% to 78.3% depending on the studies.Conclusions: The living donors’ morbidity and mortality is high, currently representing the main restriction in the development of LDLT. Some promising techniques, such as the donor portal vein flow modulation could lead to the further development of LDLT.

CRITICAL EVALUATION OF LIVING DONORS FOR LIVING DONOR LIVER TRANSPLANTATION.

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S174
Author(s):  
Kimberly L. Beavers ◽  
Michael W. Fried ◽  
Steve L. Zacks ◽  
Jeffrey H. Fair ◽  
Mark W. Johnson ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Critical Evaluation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation

Living Donors Ages 60 or Older in Right Lobe Living Donor Liver Transplantation

2015 ◽  
Vol 99 (3) ◽  
pp. e16-e17 ◽  
Author(s):  
Seong Hoon Kim ◽  
Seung Duke Lee ◽  
Young Kyu-Kim ◽  
Sang-Jae Park
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Right Lobe

Living Donor Liver Transplantation for Acute Liver Failure

2021 ◽  
pp. 241-258
Author(s):  
Lainie Friedman ◽  
J. Richard Thistlethwaite, Jr
Keyword(s):  
Liver Transplantation ◽  
Liver Failure ◽  
Liver Transplant ◽  
Acute Liver Failure ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Poor Outcomes

Acute liver failure (ALF), or fulminant hepatic failure, affects approximately two to three thousand patients (adults and children) annually in the United States and accounts for approximately eight percent of all liver transplants. Liver transplant for ALF is complicated by the fact that many patients who present with ALF spontaneously recover; however, the severe time constraints that ALF poses means that patients with ALF are usually listed for deceased donor liver transplant, and potential living donors begin donor evaluations even before it is known whether a transplant will be necessary. ALF was initially a contraindication to living donor liver transplantation (LDLT) both because of poor outcomes and because of concerns that the living donors did not have adequate time to give an informed and voluntary consent. Results have improved and ALF in now an accepted indication for LDLT. This chapter examines the ethical issues raised by LDLT in the setting of ALF.

Feelings of Living Donors About Adult-to-Adult Living Donor Liver Transplantation

2008 ◽  
Vol 31 (4) ◽  
pp. 263-272 ◽  
Author(s):  
Tomoko Kusakabe ◽  
Shinji Irie ◽  
Naomi Ito ◽  
Keiko Kazuma
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation

Quality of life of living donors before and after living donor liver transplantation

2003 ◽  
Vol 35 (8) ◽  
pp. 2961-2963 ◽  
Author(s):  
M Walter ◽  
G Dammann ◽  
C Papachristou ◽  
A Pascher ◽  
P Neuhaus ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Living Donors ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Before And After
Sign in / Sign up

Export Citation Format

Share Document